Clinical Trials Browser

OTHER × Neoplasms, Second Primary × Drug Therapy × Clear all

NCT06531629 2024-08-06

Risk-based Screen and Prognostic Analysis for Second Primary Malignancies in Kidney Cancer Patients

72,408 enrolled

Kidney Neoplasms, Neoplasms, Second Primary

NCT02283424 2014-11-05

Icotinib as the Adjunctive Treatment After Surgery in Stage I-IIIB Lung Adenocarcinoma Patients With EGFR Gene Mutation

Phase 4 Unknown

Neoplasms, Second Primary